1316924--2/6/2007--TRUEYOU.COM

related topics

{stock, price, share}

{product, liability, claim}

{regulation, change, law}

{personnel, key, retain}

{provision, law, control}

{control, financial, internal}

{condition, economic, financial}

{acquisition, growth, future}

{stock, price, operating}

Risks Related to the Company We have a history of large operating losses. We need additional capital to meet our working capital requirements and debt service and will be required to curtail our operations and / or our planned expansion if it is not available. Our Cosmedicine line of products may not be successful. We have only one supplier for our Cosmedicine products. We are dependent on our relationships with Sephora and Johns Hopkins The demand for our products and services may be adversely affected by changes in the economy. We depend on our senior management and key employees, the loss of which could adversely affect our operations. Government regulation may affect our ability to carry out our business plan and may change from time to time. We are subject to corporate practice of medicine prohibitions. We are subject to fee-splitting prohibitions. We are exposed to possible liability in excess of insurance coverage. We are subject to regulation by the FDA. We are subject to regulation by Federal Trade Commission. Risks Related to Our Common Stock Plans to increase the authorized number of shares and effect a reverse stock split could have an adverse effect on the market value of our Common Stock. Certain provisions of our charter documents and Delaware law could discourage potential acquisition proposals and could deter, delay or prevent a change in control of our company that our stockholders consider favorable and could depress the market value of our Common Stock. Future sales of our Common Stock could depress our market price and diminish the value of your investment. Our Common Stock price could be volatile, which could result in substantial losses for investors. Because our shares are deemed penny stocks, you may have difficulty selling them in the secondary trading market.

Full 10-K form ▸